Clinical Trials Browser

Phase 3 × Interventional × Thyrotropin Alfa × Clear all

NCT04971473 2024-03-28

Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal

Phase 3 Completed

EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT00415233 2023-12-19

HiLo

Phase 3 Unknown

EndocrineHead & Neck

Thyroid Cancer, Papillary, Head and Neck Neoplasms, Adenocarcinoma, Follicular

NCT04964284 2023-10-23

Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer

Phase 3 Unknown

EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT01837745 2023-05-17

ESTIMABL2

Phase 3 Active not recruiting

EndocrineHead & Neck

Low Risk Differentiated Thyroid Cancer

NCT00196729 2015-03-18

Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration

Phase 3 Completed

Thyroid Neoplasms

NCT00295763 2015-03-18

A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.

Phase 3 Completed

EndocrineHead & Neck

Thyroid Cancer, Papillary, Adenocarcinoma, Follicular

NCT00435851 2007-02-19

Estimabl

Phase 3 Unknown

Thyroid Neoplasms